Evidence map›Paper›PMID 26225140›Full record

Trial reportAlzheimer's research & therapy2015

An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter.

Brendan P Lucey, Celedon Gonzales, Ujjwas Das, Jinhe Li, Eric R Siemers, J Randall Slemmon, Randall J Bateman, Yafei Huang, Gerard B Fox, Jurgen A H R Claassen and 13 more

Open access · goldAbstract readClinical TrialComparative StudyObservational Study
In one paragraph

Trial report in Alzheimer's research & therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Pharmacological and Toxicological Properties of the Potent OralThe Journal of pharmacology and experimental therapeutics · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 14 institutions in 3 countries.

Brendan P LuceyDepartment of Neurology, Washington University School of Medicine, Campus Box 8111, 660 South Euclid Avenue, St Louis, MO 63110 USA ; Hope Center for Neurological Disorders, Department of Neurology, Washington University School of Medicine, Campus Box 8111, 660 South Euclid Avenue, St Louis, MO 63110 USA.
Celedon GonzalesEli Lilly and Company, Lilly Corporate Center, 893 South Delaware Avenue, Indianapolis, IN 46285 USA.
Ujjwas DasAbbVie Inc., 1 N. Waukegan Road, North Chicago, IL 6004 USA.
Jinhe LiAbbVie Inc., 1 N. Waukegan Road, North Chicago, IL 6004 USA.
Eric R SiemersEli Lilly and Company, Lilly Corporate Center, 893 South Delaware Avenue, Indianapolis, IN 46285 USA.
J Randall SlemmonJohnson and Johnson, One Johnson & Johnson Plaza, New Brunswick, NJ 08933 USA.
Randall J BatemanDepartment of Neurology, Washington University School of Medicine, Campus Box 8111, 660 South Euclid Avenue, St Louis, MO 63110 USA ; Hope Center for Neurological Disorders, Department of Neurology, Washington University School of Medicine, Campus Box 8111, 660 South Euclid Avenue, St Louis, MO 63110 USA.
Yafei HuangDepartment of Medicine, St. Luke's Hospital, 232 South Woodsmill Road, Chesterfield, MO 63017 USA.
Gerard B FoxAbbVie Inc., 1 N. Waukegan Road, North Chicago, IL 6004 USA.
Jurgen A H R ClaassenDepartment of Geriatric Medicine, Donders Institute for Brain, Cognition, and Behaviour, Radboud Alzheimer Center, Radboud University Medical Center, Route 925, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
Diane SlatsDepartment of Geriatric Medicine, Donders Institute for Brain, Cognition, and Behaviour, Radboud Alzheimer Center, Radboud University Medical Center, Route 925, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
Marcel M VerbeekDepartment of Neurology, 830 TML, Neurochemistry Lab, Radboud University Nijmegen Medical Center, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
Gary TongLundbeck LLC, Four Parkway North, Deerfield, IL 60015 USA.
Holly SoaresBristol-Myers Squibb, 311 Pennington-Rocky Hill Road, Pennington, NJ 08534 USA.
Mary J SavageMerck and Company, RY50-1D-131, 126 East Lincoln Avenue, PO Box 2000, Rahway, NJ 07065 USA.
Matthew KennedyMerck and Company, 33 Avenue Louis Pasteur, Boston, MA 02115 USA.
Mark FormanMerck and Company, 2000 Galloping Hill Road, Kenilworth, NJ 07033 USA.
Magnus SjögrenMental Health Centre Ballerup, Capital Region of Denmark, Maglevanget 2, 2750, Ballerup, Denmark.
Richard MargolinCereSpir, Inc., 41 Madison Avenue, 31st Floor, New York, NY 10010 USA.
Xia ChenBoeringher Ingelheim, 900 Ridgebury Road, Ridgefield, CT 06877 USA.
Martin R FarlowDepartment of Neurology, Indiana University School of Medicine, Goodman Hall, Suite 4700, 355 West 16th Street, Indianapolis, IN 46202 USA.
Robert A DeanEli Lilly and Company, Lilly Corporate Center, 893 South Delaware Avenue, Indianapolis, IN 46285 USA.
Jeffrey F WaringAbbVie Inc., 1 N. Waukegan Road, North Chicago, IL 6004 USA.
AbbVie (United States) · USEli Lilly (United States) · USMerck & Co., Inc., Rahway, NJ, USA (United States) · USRadboud University Nijmegen · NLBoehringer Ingelheim (United States) · USBristol-Myers Squibb (United States) · USCapital Region of Denmark · DKHope Center for Neurological Disorders · USIndiana University – Purdue University Indianapolis · USJohnson & Johnson (United States) · USLundbeck (United States) · USRadboud University Medical Center · NLSt. Luke's Hospital · USWashington University in St. Louis · US

Funding

Smartphone-Based "Burst" Cognitive AssessmentsP01AG003991 · NIA · WASHINGTON UNIVERSITY · PI CHENGJIE XIONG · 1985 to 2026
$69.5M
WASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 1985 to 2019
$52.1M
Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Washington University Institute of Clinical and Translational SciencesKL2TR000450 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$8.8M
CNS and Plasma Amyloid--Beta Kinetics in Alzheimer's DiseaseR01NS065667 · NINDS · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 2008 to 2016
$4.6M
amyloid-beta metabolism/humans/Alzheimer's DiseaseK08AG027091 · NIA · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 2005 to 2006
$340k
NCATS NIH HHS KL2 TR000450NCATS NIH HHS UL1 TR000448NCRR NIH HHS UL1 RR024992NIA NIH HHS K08 AG027091NIA NIH HHS K08 AG027091-01NIA NIH HHS K23 AG 0309601NIA NIH HHS P01 AG003991NIA NIH HHS P01 AG03991-22NIA NIH HHS P50 AG005681NIA NIH HHS P50 AG05681-22NINDS NIH HHS 2-R-01-NS065667-05NINDS NIH HHS R01 NS065667
6 · The paper itself

Abstract

introductionAmyloid-β (Aβ) has been investigated as a diagnostic biomarker and therapeutic drug target. Recent studies found that cerebrospinal fluid (CSF) Aβ fluctuates over time, including as a diurnal pattern, and increases in absolute concentration with serial collection. It is currently unknown what effect differences in CSF collection methodology have on Aβ variability. In this study, we sought to determine the effect of different collection methodologies on the stability of CSF Aβ concentrations over time.

methodsGrouped analysis of CSF Aβ levels from multiple industry and academic groups collected by either lumbar puncture (n=83) or indwelling lumbar catheter (n=178). Participants were either placebo or untreated subjects from clinical drug trials or observational studies. Participants had CSF collected by lumbar puncture or lumbar catheter for quantitation of Aβ concentration by enzyme linked immunosorbent assay. Data from all sponsors was converted to percent of the mean for Aβ40 and Aβ42 for comparison. Repeated measures analysis of variance was performed to assess for factors affecting the linear rise of Aβ concentrations over time.

resultsAnalysis of studies collecting CSF via lumbar catheter revealed tremendous inter-subject variability of Aβ40 and Aβ42 as well as an Aβ diurnal pattern in all of the sponsors' studies. In contrast, Aβ concentrations from CSF samples collected at two time points by lumbar puncture showed no significant differences. Repeated measures analysis of variance found that only time and draw frequency were significantly associated with the slope of linear rise in Aβ40 and Aβ42 concentrations during the first 6 hours of collection.

conclusionsBased on our findings, we recommend minimizing the frequency of CSF draws in studies measuring Aβ levels and keeping the frequency standardized between experimental groups. The Aβ diurnal pattern was noted in all sponsors' studies and was not an artifact of study design. Averaging Aβ concentrations at each time point is recommended to minimize the effect of individual variability. Indwelling lumbar catheters are an invaluable research tool for following changes in CSF Aβ over 24-48 hours, but factors affecting Aβ concentration such as linear rise and diurnal variation need to be accounted for in planning study designs.

Indexed as

Catheters, IndwellingAdultAgedAlzheimer DiseaseAmyloid beta-PeptidesAnalysis of VarianceEnzyme-Linked Immunosorbent AssayFemaleHumansLinear ModelsMaleMiddle AgedPeptide FragmentsPhotoperiodReproducibility of ResultsSpinal PunctureAmyloid beta-Peptidesamyloid beta-protein (1-40)amyloid beta-protein (1-42)Peptide Fragments

Identifiers

PMID26225140
PMCPMC4518529
OpenAlexW2159297126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.